Stephen R. Brady - Jan 3, 2024 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
President and CEO, Director
Signature
/s/ Nicholas Maestas, Attorney-in-Fact
Stock symbol
TPST
Transactions as of
Jan 3, 2024
Transactions value $
$0
Form type
4
Date filed
1/5/2024, 04:41 PM
Previous filing
Oct 13, 2023
Next filing
Jul 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Employee Stock Option (right to buy) Award $0 +250K $0.00 250K Jan 3, 2024 Common Stock 250K $4.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest in a series of 48 equal monthly installments measured from January 3, 2024, subject to the Reporting Person's continued service.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney